64
Participants
Start Date
December 27, 2021
Primary Completion Date
December 19, 2022
Study Completion Date
March 19, 2023
Angiotensin II
Patients with Delta-renin \>= 3.7 micro-unit/mL are at high risk for AKI. Patients who have a high delta-renin and a postoperative hypotension requiring vasopressors ad will be randomized. After randomization patients will receive intravenous infusion with the investigational drug.
Control
Patients with Delta-renin \>= 3.7 micro-unit/mL are at high risk for AKI. Patients who have a high delta-renin and a postoperative hypotension requiring vasopressors ad will be randomized. After randomization patients will receive intravenous infusion with placebo
University Hospital Muenster, Münster
Collaborators (1)
German Research Foundation
OTHER
Universität Münster
OTHER